Vmbook Online ordering
Vanguard Telecom Services Etf
VOX is the stock symbol for the Vanguard MSCI ACWI ETF, which is an exchange-traded fund (ETF) that tracks the performance of the MSCI All Country World Index (ACWI). The MSCI ACWI is a widely followed stock market index that includes large- and mid-cap stocks from developed and emerging markets.
Here are some key financial metrics and growth prospects for the Vanguard MSCI ACWI ETF (VOX):
1. Net Assets: As of February 2023, the net assets of VOX are approximately $10.4 billion.
2. Market Capitalization: The market capitalization of VOX is around $10.4 billion, which makes it a mid-cap ETF.
3. Expense Ratio: The expense ratio of VOX is 0.10%, which is relatively low compared to other ETFs in the market.
4. Yield: The 12-month yield for VOX is around 2.24%.
5. Holdings: VOX holds a diversified portfolio of around 1,300 stocks from various sectors and countries. The top 10 holdings of VOX include well-known companies such as Microsoft, Apple, Amazon, Alphabet (Google), and Facebook.
6. Performance: VOX has a strong track record of long-term performance, with a 5-year annualized return of around 10%.
7. Earnings: The earnings per share (EPS) of VOX have been growing steadily over the past few years, with a 5-year annualized EPS growth rate of around 12%.
8. Valuation: VOX trades at a price-to-earnings (P/E) ratio of around 21, which is slightly below the industry average.
9. Growth Prospects: VOX has strong growth prospects, with a 5-year annualized revenue growth rate of around 10%.
10. Dividend: VOX pays a semi-annual dividend, with a current dividend yield of around 2.24%.
Overall, VOX is a well-diversified ETF that offers investors exposure to a broad range of sectors and geographies, with a strong track record of performance and growth prospects. However, it's important to keep in mind that past performance is not a guarantee of future results, and investors should always conduct thorough research and consult with a financial advisor before making any investment decisions.